<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2021-6.3.8</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-2849</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОРФОЛОГИЯ, ФИЗИОЛОГИЯ И ПАТОФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MORPHOLOGY, PHYSIOLOGY AND PATHOPHYSIOLOGY</subject></subj-group></article-categories><title-group><article-title>Роль «белков старости» и маркеров дисфункции эндотелия в развитии синдрома диабетической стопы</article-title><trans-title-group xml:lang="en"><trans-title>The role of «old age proteins» and endotelial dysfunction markers in diabetic foot syndrome development</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6682-8359</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дамдинов</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Damdinov</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> ассистент кафедры анатомии с курсом топографической анатомии и оперативной хирургии</p><p>672090, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p> Assistant of the Department of Anatomy with a course in Topographic Anatomy and Operative Surgery</p><p>672090, Chita, Gorky St., 39a, Russia </p></bio><email xlink:type="simple">ruslan75.ru@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3485-5176</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаповалов</surname><given-names>К. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shapovalov</surname><given-names>K. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p> доктор медицинских наук, профессор, заведующий кафедрой анестезиологии, реанимации и интенсивной терапии</p><p> 672090, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p> Doctor of Medical Sciences, Professor, Head of the Department of Anesthesiology, Resuscitation and Intensive Care </p><p>672090, Chita, Gorky St., 39a, Russia </p></bio><email xlink:type="simple">shkg26@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8973-753X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Троицкая</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Troitskaya</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> ассистент кафедры госпитальной хирургии </p><p>672090, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>Assistant of the Department of Hospital Surgery </p><p>672090, Chita, Gorky St., 39a, Russia </p></bio><email xlink:type="simple">troicachita@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2021</year></pub-date><volume>6</volume><issue>3</issue><fpage>77</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дамдинов Р.И., Шаповалов К.Г., Троицкая Н.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Дамдинов Р.И., Шаповалов К.Г., Троицкая Н.И.</copyright-holder><copyright-holder xml:lang="en">Damdinov R.I., Shapovalov K.G., Troitskaya N.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/2849">https://www.actabiomedica.ru/jour/article/view/2849</self-uri><abstract><sec><title> Обоснование</title><p> Обоснование. Сахарный диабет на протяжении десятилетий является самым распространенным  эндокринным заболеванием в мире. Темпы роста данного заболевания стали носить характер мировой пандемии. При сахарном диабете резко возрастают риски развития макрососудистых осложнений, что зачастую приводит к  таким серьезным осложнениям, как диабетическая стопа. </p></sec><sec><title>Цель исследования</title><p>Цель исследования: определение уровней «белков  старости» и маркеров дисфункции эндотелия, характерных  для синдрома диабетической стопы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Исследование проводилось в  Лаборатории экспериментальной и клинической биохимии  и иммунологии НИИ Молекулярной медицины Читинской государственной медицинской академии и включало  определение содержания маркеров дисфункции эндотелия  (гомоцистеин, эндотелин, NOx, NO2, NO3), ММР-9, GDF- 15/MIC-1, CCL11 путем твердофазного иммуноферментного  анализа. </p></sec><sec><title>Результаты исследования</title><p>Результаты исследования. Для синдрома диабетической стопы характерен уровень GDF-15/MIC-1 равный 1440 пг/мл  и более, и уровень NOx, составляющий 20 мкмоль/л и  более. При достижении указанных пороговых значений, вероятность развития синдрома диабетической стопы у  больных сахарным диабетом, возрастает в 10 и 4 раза  соответственно, что подтверждено результатами статистического анализа в программе IBM SPSS Statistics Version 25.0.</p></sec><sec><title>Выводы</title><p>Выводы. Увеличение уровня белка GDF-15/MIC-1 и метаболитов оксида азота у больных с сахарным диабетом II типа можно считать предикторами синдрома диабетической  стопы. Включение данных показателей в структуру регрессионной модели позволяет диагностировать доклиническую стадию синдрома  диабетической стопы, что в перспективе позволит  оптимизировать тактику ведения и лечения данных  пациентов.  </p></sec></abstract><trans-abstract xml:lang="en"><sec><title> Background</title><p> Background. Diabetes mellitus has been the most common endocrine disease in the world for decades. The growth rate of this disease has become a global pandemic. With diabetes, the risk of developing macrovascular complications increases dramatically, this often leads to serious complications such as diabetic foot.</p><p>The aim of the study was to determine the levels of «old age proteins» and markers of endothelial dysfunction characteristic to the diabetic foot syndrome.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study was carried out in the Laboratoryof experimental and clinical biochemistry and immunology of the research Institute of Molecular medicine of the Chita State Medical Academy and  included determining of endothelial dysfunction markers (homocysteine, endothelin, NOx, NO2, NO3), MMP-9, GDF-15/MIC-1, CCL11 by solid-phase enzyme immunoassay. </p></sec><sec><title>Result</title><p>Result. Diabetic foot syndrome is characterized by the level of GDF-15/MIC-1 equal to 1440 PG/ml or more, and by NOx that equal to 20 mmol/l or more. When these thresholds are reached, the probability of developing diabetic foot syndrome in diabetic patients increases in 10 and 4 times, respectively, which is confirmed by the results of statistical analysis in the IBM SPSS Statistics Version 25.0 program.</p></sec><sec><title>Conclusions</title><p>Conclusions. Increased levels of GDF-15/MIC-1 protein and nitric oxide metabolites in patients with type II diabetes can be considered as predictors of diabetic foot syndrome. The inclusion of these indicators in the structure of the regression model allows us to diagnose the preclinical stage of diabetic foot syndrome, which in the future will allow us to optimize the management and treatment of these patients. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>синдром диабетической стопы</kwd><kwd>белки старости</kwd><kwd>дисфункция эндотелия</kwd><kwd>GDF-15/MIC-1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>diabetic foot syndrome</kwd><kwd>old age proteins</kwd><kwd>endothelial dysfunction</kwd><kwd>GDF-15/MIC-1</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Standards of Medical Care in Diabetes-2021: Improving Care and Promoting Health in Populations. Diabetes Care. 2021; 44 (1): 7–14. doi.org/10.2337/dc21-S001</mixed-citation><mixed-citation xml:lang="en">Standards of Medical Care in Diabetes-2021: Improving Care and Promoting Health in Populations. Diabetes Care. 2021; 44 (1): 7–14. doi.org/10.2337/dc21-S001</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Standards of Medical Care in Diabetes-2021: Summary of Revisions. Diabetes Care. 2021; 44 (1): 4– 6. doi.org/10.2337/dc21-Srev</mixed-citation><mixed-citation xml:lang="en">Standards of Medical Care in Diabetes-2021: Summary of Revisions. Diabetes Care. 2021; 44 (1): 4–6. doi.org/10.2337/dc21-Srev</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И. И., Шестакова М. В. Сахарный диабет типа 1: реалии и перспективы. М.: Медицинское информационное агентство; 2016.</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV. Type 1 diabetes mellitus: realities and prospects. Moscow: Medicinskoe informacionnoe agentstvo. 2016 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: IDF; 2017; 148</mixed-citation><mixed-citation xml:lang="en">International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: IDF. 2017; 148</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И. И., Шестакова М. В., Майоров А. Ю., Викулова О. К., Галстян Г. Р., Кураева Т. Л. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Сахарный диабет. 2019; 22 (1): 10. doi: 10.14341/DM221S1</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, MayorovA Yu, Vikulova OK, Galstyan GR, Kuraeva TL. et al. Algorithms of specialized medical care for patients with diabetes mellitus. Diabetes. 2016; 19 (2): 104–112. doi:10.14341/DM2004116–17</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И. И., Шестакова М. В., Галстян Г. Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016; 19 (2):104–112. doi: 10.14341/DM2004116–17</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Galstyan GR. Prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes. 2016; 19 (2):104–112. doi: 10.14341/DM2004116–17</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ахметова Е. С., Ларева Н. В., Мудров В. А., Гергесова Е. Е. Особенности течения беременности при гестационном сахарном диабете и прогнозирование диабетической фетопатии. Журнал акушерства и женских болезней. 2017; 66 (4): 14–24. doi.org/10.17816/JOWD66414–24</mixed-citation><mixed-citation xml:lang="en">Akhmetova ES, Lareva NV, Mudrov VA, Gergesova EE. Features of the course of pregnancy in gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of obstetrics and women’s deseases. 2017; 66 (4): 14–24. doi.org/10.17816/JOWD66414–24 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И. А., Шестакова М. В. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным федерального регистра сахарного диабета. Сахарный диабет. 2017; 20 (1): 13–41. doi.org/10.14341/DM8664</mixed-citation><mixed-citation xml:lang="en">Dedov IA, Shestakova MV. Epidemiology of Diabetes Mellitus in the Russian Federation: Clinical and Statistical Analysis Based on Data from the Federal Register of Diabetes Mellitus. Diabetes. 2017; 20 (1): 13–41. doi.org/10.14341/DM8664 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Галстян Г. Р., Викулова О. К., Исаков М. А., Железнякова А. В., Серков А. А., Егорова Д. Н. и др. Эпидемиология синдрома диабетической стопы и ампутаций нижних конечностей в Российской Федерации по данным Федерального регистра больных сахарным диабетом (2013–2016 гг.). Сахарный диабет. 2018; 21 (3): 170–177. doi: 10.14341/DM9688</mixed-citation><mixed-citation xml:lang="en">Galstyan GR, Vikulova OK, Isakov MA, Zheleznyakova AV, Serkov AA, Egorova DN. et al. Epidemiology of diabetic foot syndrome and lower limb amputations in the Russian Federation according to the Federal Register of Diabetic Patients (2013–2016). Diabetes. 2018; 21 (3):170–177. doi: 10.14341/DM9688</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miyajima S, Shirai A, Yamamoto S. Risk factors for major amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract. 2006; 7 (3): 272–279. doi.org/10.1016/j.diabres.2005.07.005</mixed-citation><mixed-citation xml:lang="en">Miyajima S, Shirai A, Yamamoto S. Risk factors for major amputations in diabetic foot gangrene patients. Diabetes Res ClinPract. 2006; 7 (3): 272–279. doi.org/10.1016/j.diabres.2005.07.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И. И. Сахарный диабет: развитие технологий в диагностике, лечении и профилактике (пленарная лекция). Сахарный диабет. 2010; (3): 6–13</mixed-citation><mixed-citation xml:lang="en">Dedov II. Diabetes mellitus: development of technologies in diagnosis, treatment and prevention (plenary lecture). Diabetes. 2010; (3): 6–13 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Оболенский В. Н., Никитин В. Г., Леваль П. Ш., Ермолова Д. А., Молочников А. Ю., Ермолов А. А. Лечебнодиагностический алгоритм при синдроме диабетической стопы: стандарты и новые технологии. РМЖ: хирургия. 2012; (12): 585–598</mixed-citation><mixed-citation xml:lang="en">Obolensky VN, Nikitin VG, Leval PSh, Ermolova DA, Molochnikov AYu, Ermolov AA. Medical and diagnostic algorithm for diabetic foot syndrome: standards and new technologies. Russian medical journal: surgery. 2012; (12): 585–598 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Черданцев Д. В., Николаева Л. П., Степаненко А. В., Константинов Е. П. Диабетические макроангиопатии: методы восстановления кровотока. Фундаментальные исследования. 2010; (1): 95–99</mixed-citation><mixed-citation xml:lang="en">Cherdantsev DV, Nikolaeva LP, Stepanenko AV, Konstantinov EP. Diabetic macroangiopathies: methods of restoring blood flow. Fundamental’nye issledovaniya. 2010; (1): 95–99 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бродский И. Н., Деев Р. В. Место ангиогенной терапии в программе лечения пациентов с критической ишемией нижних конечностей. Медицинский альманах. Хирургия. 2013; 5 (29): 156–157. doi.org/10.21145</mixed-citation><mixed-citation xml:lang="en">Brodsky IN, Deev RV. The place of angiogenic therapy in the treatment program for patients with critical lower limb ischemia. Medicinskij al’manah. Hirurgiya. 2013; 5 (29): 156–157. doi.org/10.21145 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Villeda SA, Luo J, Mosher KI et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477: 90–94. doi.org/10.1038/nature10357</mixed-citation><mixed-citation xml:lang="en">Villeda S, Luo J, Mosher K et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477: 90–94. doi.org/10.1038/nature10357</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bitto A, Kaeberlein M. Rejuvenation: it’s in our blood. Cell Metab. 2014; 20: 2–4. doi: 10.1016/j.cmet.2014.06.007</mixed-citation><mixed-citation xml:lang="en">Bitto A, Kaeberlein M. Rejuvenation: it’s in our blood. Cell Metab. 2014; 20: 2–4. doi.org/10.1016/j.cmet.2014.06.007</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Castellano JM, Kirby ED, Wyss-Coray T. Blood-Borne Revitalization of the Aged Brain. JAMA Neurol. 2015; 72 (10): 1191–1194. doi.org/10.1001/jamaneurol. 2015.1616</mixed-citation><mixed-citation xml:lang="en">Castellano JM, Kirby ED, Wyss-Coray T. Blood-Borne Revitalization of the Aged Brain. JAMA Neurol. 2015; 72 (10): 1191–1194. doi.org/10.1001/jamaneurol.2015.1616</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Кузник Б. И., Гусева Е. С., Давыдов С. О., Смоляков Ю. Н., Цыбиков Н. Н. Влияние «белка молодости» GDF11 и «белков старости» CCL11, GDF15, JAM-A на состояние кардиогемодинамических функций у женщин с гипертонической болезнью. Артериальная гипертензия. 2019; 25 (5): 527–539. doi.org/10.18705/1607-419X-2019-25-5-527-539</mixed-citation><mixed-citation xml:lang="en">Kuznik BI, Guseva ES, Davydov SO, SmolyakovYuN, Tsybikov NN. Influence of «youth protein» GDF11 and «old age proteins» CCL11, GDF15, JAM-A on the state of cardiohemodynamic functions in women with essential hypertension. Arterial’naya gipertenziya. 2019; 25 (5): 527–539. doi.org/10.18705/1607-419X-2019-25-5-527-539 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Corre J, Hebraud B, Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl Med. 2013; 12: 946–952. doi.org/10.5966/sctm.2013–0055</mixed-citation><mixed-citation xml:lang="en">Corre J, Hebraud B, Bourin P. Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl Med. 2013; 12: 946–952. doi.org/10.5966/sctm.2013–0055</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Corre J, Labat E, Espagnolle N, Hébraud B, Avet-Loiseau H, Rousse M. et al. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res. 2012; 72: 1395–1406. doi.org/10.1158/0008–5472.CAN-11-0188</mixed-citation><mixed-citation xml:lang="en">Corre J, Labat E, Espagnolle N, Hébraud B, Avet-Loiseau H, Rousse M. et al. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res. 2012; 72: 1395–1406. doi.org/10.1158/0008–5472.CAN-11–0188</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Eggers KM, Kempf T, Wallentin L, Wollert K, Lind L. Change in growth differentiation factor 15 сoncentrations over time independently predicts mortality in communitydwelling elderly individuals. Clin Chem. 2013; 59 (7): 1091–1098. doi.org/10.1373/clinchem.2012.201210</mixed-citation><mixed-citation xml:lang="en">Eggers KM, Kempf T, Wallentin L, Wollert K, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in communitydwelling elderly individuals. Clin Chem. 2013; 59 (7): 1091–1098. doi.org/10.1373/clinchem.2012.201210</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wiklund F, Bennet A, Magnusson P, Eriksson U, Lindmark F, Wu L. et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010; 9 (6): 1057–1064. doi.org/10.1111/j. 1474–9726.2010.00629</mixed-citation><mixed-citation xml:lang="en">Wiklund F, Bennet A, Magnusson P, Eriksson U, Lindmark F, Wu L. et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell. 2010; 9 (6): 1057–1064. doi.org/10.1111/j.1474–9726.2010.00629.x</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Левин Г. Я, Кудрицкий С. Ю, Изумрудов М. Р. Корреляция изменений гемореологии и микроциркуляции при синдроме диабетической стопы. Регионарное кровообращение и микроциркуляция. 2011; 10 (3): 44–48. doi.org/10.2488 4/1682-6655-2011-10-3-44-48</mixed-citation><mixed-citation xml:lang="en">Levin GYa, Kudritskiy SYu, Izumrudov MR. Correlation of changes in haemorheology and microcirculation in diabetic foot syndrome. Regionarnoe krovoobrashchenie i mikrocirkulyaciya. 2011; 10 (3): 44–48. doi.org/10.24884/1682-6655-2011-10-3-44-48. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Сifte M, Ertug H, Parlak M, Akcurin G, Kardelen F. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction. DiabVaseDis Res. 2014; 11 (1): 19–25. doi.org/10.1177/1479164113508564</mixed-citation><mixed-citation xml:lang="en">Сifte M, Ertug H, Parlak M, Akcurin G, Kardelen F. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction. Diab Vase Dis Res. 2014; 11 (1): 19–25. doi.org/10.1177/1479164113508564</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Власов Т. Д., Петрищев Н. Н., Лазовская О. А. Дисфункция эндотелия. Правильно ли мы понимаем этот термин? Вестник анестезиологии и реаниматологии. 2020; 17 (2): 76–84. doi.org/10.21292/2078-5658-2020-17-2-76-84</mixed-citation><mixed-citation xml:lang="en">Vlasov TD, Petrishchev NN, Lazovskaya OA. Endothelial dysfunction. Do we understand this term correctly? Bulletin of Anesthesiology and Reanimatology. 2020; 17 (2): 76–84. doi.org/10.21292/2078-5658-2020-17-2-76-84. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева Е. Н., Шумахер Г. И., Хорева М. А., Осипова И. В. Дисфункция эндотелия – ключевое звено в патогенезе атеросклероза. Российский кардиологический журнал. 2010; 82 (2): 84–91</mixed-citation><mixed-citation xml:lang="en">Vorobieva EN, Schumacher GI, Khoreva MA, Osipova IV. Endothelial dysfunction is a key link in the pathogenesis of atherosclerosis. Russian journal of cardiology. 2010; 82 (2): 84–91. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Михайличенко М. И., Шаповалов К. Г., Мудров В. А., Груздева О. С. Динамика матриксных металлопротеиназ при местной холодовой травме. Acta biomedica scientifica. 2019; 4 (5): 79–83. doi.org/10.29413/ABS.2019-4.5.13</mixed-citation><mixed-citation xml:lang="en">Mikhailichenko MI, Shapovalov KG, Mudrov VA, Gruzdeva OS. Dynamics of matrix metalloproteinases in local cold injury. Acta biomedical scientifica. 2019; 4 (5): 79–83. doi.org/10.29413/ABS.2019–4.5.13. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2011. Available from: http://www.icmje.org. [Date of access: 01.09.2020]</mixed-citation><mixed-citation xml:lang="en">International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2011. Available from: http://www.icmje.org. [date of access: 01.09.2021]</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lang TA, Altman DG. Statistical analyses and methods in the published literature: The SAMPL guidelines. Medical Writing. 2016; 25 (3): 31–36. doi.org/10.18243/eon/2016.9.7.4</mixed-citation><mixed-citation xml:lang="en">Lang TA, Altman DG. Statistical analyses and methods in the published literature: The SAMPL guidelines. Medical Writing. 2016; 25 (3): 31–36. doi.org/10.18243/eon/2016.9.7.4</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В. А. Алгоритмы статистического анализа количественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; (1):140– 150</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Statistical analysis algorithms of quantitative features in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; (1): 140–150. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В. А. Алгоритмы статистического анализа качественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; (1):151–163</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Statistical analysis algorithms of qualitative features in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; (1):151–163. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В. А. Алгоритмы регрессионного анализа данных в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; (2): 177–190</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Algorithms for performing data correlation analysis in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; 2: 177–190. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Булаева Н. И., Голухова Е. З. Эндотелиальная дисфункция и оксидативный стресс: роль в развитии кардиоваскулярной патологии. Креативная кардиология. 2013; 1: 14–22</mixed-citation><mixed-citation xml:lang="en">Bulaeva NI, Golukhova EZ. Endothelial dysfunction and oxidative stress: a role in the development of cardiovascular pathology. Creative cardiology. 2013; 1: 14–22</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Пузик С. Г. Эндотелиальная дисфункция в патогенезе артериальной гипертензии и прогрессировании атеросклероза. Семейная медицина. 2018; 76 (2): 69–74</mixed-citation><mixed-citation xml:lang="en">Puzik SG. Endothelial dysfunction in the pathogenesis of arterial hypertension and the progression of atherosclerosis. Family medicine. 2018; 76 (2): 69–74</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
